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MicroRNAs (miRNA) expression play crucial roles in many physiologic and pathologic 
processes and are significant biomarkers for human cancer. This has fueled the need for 
the development of highly sensitive and selective detection methods for miRNAs.  
However, rapid, low cost, selective and sensitive detection of miRNAs remain a 
challenge due to their short lengths, low abundance, and sequence homology. Current 
detection platform of microarray, PCR and Northern blotting suffer from drawbacks 
including being time-consuming, low sensitivity and lack of simplicity. This work mainly 
focuses on developing a selective and sensitive hairpin smart probe (SP)-based methods 
for specific detection of selected microRNA (miRNA) target sequences. The loop 
sequence of each smart probe is perfectly complementary to the miRNA sequence of 
interest. The stem of these self-quenching SP contains a fluorophore on one end and a set 
of guanine bases on the other end are used as quenchers. The fluorescence of the SP is 
quenched by the guanine bases at room temperature and in the absence of the target. The 
SP recognizes the miRNA target sequence and it switches on its fluorescence as a result 
of the spontaneous hybridization of the SP with the target. The SP successfully 
discriminated between the perfect miRNA target and mismatch sequences. This new SP-
based method does not involve any amplification steps. When the SP was incubated with 
xiv 
 
the miRNA at 37 
o
C, the hybridization kinetics took only 40 minutes compared to room 
temperature that takes around five hours to complete. In addition, these new SPs have 
exquisite sensitivity and give a limit of detection (0.53 and 0.02 nM) and limit of 
quantitation (1.76 and 0.07 nM) for miR-21 and Let-7a respectively. This detection 
method represents a simple, fast, specific and potential diagnostic tool for the various 
























  يوسف بشير اولينكا: األسم بالكامل 
 تطوير جهاز كشف مجس ذكي لتشخيص السرطان : عنوان البحث
 كيمياء: التخصص
 8102مايو، : تاريخ الدرجة
الدقيقة دورا مهما في كثير من العمليات الفيسولوجية وعلم األمراض وتعتبر مؤشرات حيوية  RNAتلعب جزيئات 
مهمة المراض السرطان التي تصيب االنسان، وذلك دعم الحوجة لتطوير طرق ذات حساسية وانتقائية عاليتين 
كلفة منخفة، انتقائية و حساسة للكشف عن هذه الدقيقة، ولكن ايجاد طريقة سريعة، ذو  RNAجزيئات للكشف عن ل
جهاز الكشف التياري للمصفوفات الدقيقة، . الجزيئات يظل تحديا نسبة لقصر الطول، قلة الوفرة و تماثل التسلسل
PCR و جهاز التشرب الشمالي، كل هذه الطرق تعاني من مشكلة استهالك الوقت، قلة الحساسية و تعقيد الطريقة .
. الدقيقة RNAجزيئات كز على تطوير مجس دبوس ذو انتقائية وحساسية عالية لكشف النوعي لهذا البحث ير
يحتوي المجس . ذو االهتمام RNAالتسلسل الحلقي لكل مجس ذكي يكون متكامل بطريقة مثالية مع تسلسل جزئ ال
النهاية االخرى وتستخدم الذكي ذو خاصية التثبيط الذاتي على فلوروفور في نهاية ومجموعة من قواعد كونين في 
يقوم . يتم تثبيط المجس الذكي بواسطة قواعد الكوينين عند درجة حرحاة الغرفة في غياب المادة الهدف. كمثبطات
الدقيق و يتم تفعيل الفلورة نتيجة للتهجين التلقائي للمجس مع المادة  RNAالمجس بتميز تسلسل الهدف لجزئ ال
 هذه الطريقة، طريقة. الدقيق المثالي و التسلسل غير المتطابق RNAجزئ ال يقوم المجس بالتفريق بين. الهدف
الدقيق في درجة  RNAعندما يتم تحضين المجس مع جزئ ال. المجس الذكي التحتاج اي خطوات لتضخيم االشارة
  Cحرارة
o
مس دقيقة فقط مقارنة مع درجة حرار الغرفة التي تتطلب حوالي خ 01، حركية التهجيت تتطلب  37
وحد  (and 0.02 nM 0.53)باالضافة لذلك تتمتع هذه العملية بحساية ممتازة وحد كشف . ساعات التمام العملية
هذه الطريقة تمثل طريقة بسيطة، سريعة، . على التوالي 7a-Letو    miR-21ل (and 0.07 nM 1.76) التكميم 





1 CHAPTER 1 
INTRODUCTION 
1.1 Introduction to MicroRNA  
 
Micro-RNAs (miRNAs) are non-coding single-stranded RNA molecules that regulate 
several physiological and pathological processes [1-2]. Recent studies have found that the 
dysregulation of miRNA expression is closely associated with several diseases including 
lung cancer, hepatocellular carcinoma, pancreatic cancer, breast cancer and gastric 
carcinoma [3-6]. In addition, they play an important role in many biological processes 
and recognized as biomarkers in clinical diagnosis and therapy [7]. Consequently, 
miRNAs are regarded as new oncogenes or tumor suppressor genes and new biomarkers 
for the diagnosis and prediction of treatment response and prognosis [8-10]. As 
microRNAs are an important class of gene regulators in vivo, the specific and sensitive 
detection of microRNAs has become more and more important [11]. The detection of 
miRNAs is quite challenging due to their high homology, small size and low abundance 
among miRNA family members [12].  
MicroRNAs were the primary endogenous little RNAs to be found  [1, 13–16]. While 
doing hereditary examination of formative mutants of Caenorhabditis elegans, Ambros, 
and his group observed that the translation of lin-14 mRNA into LIN-14 protein was 
repressed amid its formative stage change by a little transcript of 22 nucleotides in length 
2 
 
[17]. Around a similar time, Ruvkun and his group watched a comparable marvel [17], in 
spite of the fact that Ruvkin’s inquires about concentration was lin-14 gene, while 
Ambros’ examination was on the lin-4 gene. In 1993, by joint endeavor of Ambros and 
Ruvkun groups, the main miRNA lin-4 was discovered [14, 17]. Seven years after the 
discovery of the first miRNA, the second miRNA, let-7 was found in C. elegans by 
Reinhart et al. [18] in 2000. It has been demonstrated that conversely with lin-4, the let-7 
sequence is preserved crosswise over species from flies to people [19]. This finding 
affected the investigation of miRNAs in other organisms [19] and provoked a rebellion in 
the explanation of this new class of small noncoding RNAs called miRNAs. Since then, a 
large number of miRNAs have been identified in humans, worms and Drosophila [20-
21]. Gene regulation by miRNAs plays a role in cell multiplication, cell demise, and 
tumorigenesis and in addition mammalian cell improvement [22-23].  
1.1.1 miRNA Biogenesis and Function 
It has been established that a multi-step process is important to create a developing type 
of miRNA [24]. miRNA biogenesis begins in the nucleus and in the end, brings about 
mature miRNA in the cytoplasm (Figure 1.1). Before mature miRNA is formed, primary 
miRNA (pri-miRNA), a long strand of RNA containing stem-loop structures (up to 1kb 
in length), is at first transcribed by RNA polymerase II [25], and further excised by the 
endonuclease Drosha [26]. After excision, the former pri-miRNA, termed pre-miRNA, is 
exported to the cytoplasms by the RNA-binding protein Ran-GTP and the exporter 
receptor Exportin-5 [27–29]. This pre-miRNA comprises of a long stem of roughly 25-30 
bp alongside a small loop structure. After the pre-miRNA is released from the Exportin-
5, it is cleaved by an RNase III enzyme known as Dicer, to generate mature miRNA. The 
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mature miRNA is further incorporated with the RNA-induced silencing complex (RISC), 
consisting of proteins from the Argonaute family, by which the  
 
Figure 1.1: miRNA biogenesis. miRNA is at first encoded in genomic DNA. It experiences transcription, trailed 
by a progression of prepared ventures to produce mature miRNA, which ties to mRNA, repressing protein 
translation. Adapted from Cissell et al. (2007). 
 
miRNA anneals to the 3’ untranslated region of its complementary target messenger 
RNA (mRNA) [30-31]. Once bound to the target mRNA, the miRNA can induce 
cleavage of the mRNA, regulating protein translation directly, or regulating translation 
indirectly by remaining bound to the mRNA. Because of the similarities between small 
interfering RNA (siRNA), miRNA, and piwi-interacting RNAs (piRNAs), it is important 
to differentiate between each of these small RNAs. While each of the three is about a 
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similar length, they are handled distinctively in the cell. Every one of the three is 
generated by RNase enzymes Dicer and Drosha. The cleavage of exogenous long dsDNA 
precursors in response to viral infections or artificial introduction generates small 
interfering RNAs (siRNAs), whereas the processing of genome-encoded stem-loop 
structures generates miRNAs. A recently uncovered class of small RNAs called piwi-
interacting RNAs (piRNAs) is slightly longer than miRNAs (~26-31 nucleotide) [32]. 
The proteins required for this pathway are unknown but it is known that the piRNAs 
function to silence transposons through a complex amplification process that can even 
modify histones and carry out DNA methylation [33-35]. 
1.2 miRNA Implication in Human Disease 
 
MicroRNA has been associated with various diseases, including malignancy. It assumes a 
vital part in cell science, including apoptosis, multiplication and pathological process 
[36–39]. Also, miRNAs are involved in different cellular activities, for example, insulin 
secretion [38], viral replication [41–43], neurotransmitter synthesis [42], and resistant 
reaction [43]. It can be found freely circulating in bodily fluids, for example, serum [44], 
urine [45] and saliva [46]. The utility of circulating miRNA as cancer biomarkers, 
therefore, would be highly advantageous in terms of developing rapid diagnostic tools. 
As the investigation of miRNA expands, more and more researchers are finding links 
between miRNA expression levels (the amount of miRNA in the cells) and the onset of 
cancer and other diseases [47]. Various studies have found that miRNA expression levels 
are increased (upregulated) or decreased (downregulated) in cancer cells. For instance, 
miR-15a and miR-16-1 are downregulated in B-cell chronic lymphocytic leukemia [48]; 
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miR-143 and miR-145 are downregulated in breast, prostate, cervical, and lymphoid 
cancer cells [49]; while miR-21, miR-373, and miR-520c are upregulated in breast cancer 
cells [4, 52], and miR-184 is upregulated in prostate cancer cells [51]. There are certainly 
hundreds of more miRNAs which are linked to cancer and the list grows larger as more 
and more studies are performed. Along with cancer, miRNAs have appeared to play a 
vital role in cardiovascular disease. Hammond and colleagues have discovered that in the 
presence of mutated Dicer, the enzyme which cuts pre-miRNA into mature miRNA, the 
miRNA which is essential for cardiovascular health cannot be processed. This ultimately 
results in progressive dilated cardiomyopathy, which prompts heart failure, and 
eventually death [52]. Because of the significance of miRNA in disease, it is important to 
develop miRNA based diagnostic and therapeutic techniques. Because of their 
widespread gene regulation and their effects on human wellbeing, miRNAs have 
garnered much attention in the biomedical field. 
1.2.1 miRNA as Oncogene and Tumor Suppressor Genes 
Due to the common characteristic that was observed in miRNA expression patterns, it 
has been suggested that deregulation of these miRNAs were not caused by random events 
in cancer. This led to the assumption that up-regulated miRNAs may act as oncogenes 
and down-regulated miRNAs may act as tumor suppressors [55–58]. miRNAs also 
function as tumor suppressors in different cancer types by regulating the oncogenic 
process and preventing tumor development. Kefas et al. documented the association of 
EGFR and AKT pathway activation with the aggressiveness of glioblastoma [56]. Figure 
1.2 represents the basic model of miRNAs acting as tumor suppressors and oncogenes 
proposed by Garzon et al. [54]. They proposed that, when a miRNA down-regulates the 
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expression of an oncogene, it can be categorized as a tumor suppressor and is frequently 
observed to be lost in tumor cells. The loss of function of these miRNAs may occur due 
to any abnormality in the miRNA biogenesis, such as mutation, deletion or promoter 
methylation. These might produce an abnormal expression of the target oncogene, which 
then contributes to tumor formation, which will ultimately induce cell proliferation,  
Figure 1.2: A fundamental model of miRNAs going about as tumor suppressors and oncogenes proposed by Garzon et 
al. [90].  
A) When a miRNA down-regulates the expression of an oncogene, it can be sorted as a tumor suppressor and is much 
of the time seen to be lost in tumor cells. Loss of capacity of these miRNAs may happen because of any anomalies in 
the miRNA biogenesis, for example, change cancellation or promoter methylation. These might create an anomalous 
articulation of the objective oncogene, which at that point adds to tumor development, which will, at last, incite cell 
multiplication, intrusion, angiogenesis, and diminished cell demise. 
B) MicroRNA that down-directs tumor silencer qualities can be characterized as an oncogene (oncomiR). In the event 
that it is overexpressed, it may add to tumor arrangement by angiogenesis and intrusion or by avoiding apoptosis and 







invasion, angiogenesis and decreased cell death (Figure 1.2, A). For example, it has been 
shown by Calin et al. that miR-16-1 cluster located in the chromosome 13q14 region is a 
negative regulator of the B cell lymphoma 2 proteins (BCL2), in patients with chronic 
lymphocytic leukemia (CLL) due to a genomic deletion of this region [50, 59-60].  On 
the contrary, if a miRNA that down-regulates a tumor suppressor gene is overexpressed, 
it might contribute to a tumor formation by angiogenesis and invasion by preventing 
apoptosis and increasing genetic instability (Figure 1.2, B). It has been reported that 
overexpression of the oncogenic miRNAs, mir-21, mir-155 and mir-17-92 cluster are 
linked with tumor initiation and progression by repressing the expression of tumor 
suppressor genes, such as phosphatase and tensin homologue (PTEN), and programmed 
cell death 4 (PDCD4) [61–65]. miR-17-92 cluster is one of the first oncogenic miRNAs 
that was identified by Di Leva et al., which consists of seven miRNAs: miR-17-5p, miR-
17-3p, miR-18a, miR-19a, miR-20a, miR-19b- 1, and miR-92-1 [62]. The role of miR-
17-92 cluster as an oncogene was confirmed by L. He et al. in the E μ-Myc transgenic 
mouse model for B cell lymphoma [49]. Another oncogenic miRNA, miR-21, is up-
regulated in almost all types of cancer. Its oncogenic activity was shown by J. Liu et al. 
in transgenic mouse models with alternated miRNA-21 function combined with a mouse 
model for lung cancer [64]. It should be noted though that miRNA function depends on 
the expression of its target. Depending on the cell type, some miRNAs could function as 
oncogenes, as well as tumor suppressors. Presumably, miRNAs are not responsible for a 
specific phenotype by acting on a single target; instead, they are involved in complex 
interactions with the transcriptome machinery and can simultaneously target multiple 




1.3 miRNA and Their Application in Therapeutics  
 
Because of the increasing correlation of miRNA levels with diseases, it has been 
suggested to explore various therapeutic options for miRNA function inhibition or 
delivery of miRNA in cells where the onset of disease may occur if miRNA level is 
downregulated. In order to achieve these tasks, miRNAs must be relatively examined in 
both healthy and unhealthy cells. Once a miRNA has been determined to be a suitable 
biomarker, it will be important to explore options on how to counteract the disease linked 
to the specific miRNA or miRNAs. In the event that the miRNA levels are too high, a 
few options to tackle this problem may be used. Anti-sense oligonucleotides which 
hybridize with the miRNA can be introduced, preventing the target miRNA from 
hybridizing with the 3’ UTR of the mRNA [65]. By doing this, it is possible that 
abnormal gene regulation will not occur from the target miRNA. A more effective 
technique to design antisense miRNA is to employ locked nucleic acid (LNA) probes 
rather than DNA oligonucleotide probes. LNAs contain a 2’-O-4’C methylene bridge on 
the furanose ring which results in a more rigid double-stranded nucleic acid structure that 
is more thermally stable as well. This could prevent the separation of the hybrid between 
target miRNA and antisense oligonucleotide. Additionally, it has been discovered that 
antagomirs, anti-sense oligonucleotides which were conjugated to cholesterol to aid in 
cellular delivery, might be useful therapeutic agents for tumors or other diseased cells. In 
a study by Krutzfeldt and colleagues, it was determined that 7 cholesterol-modified 
antagomirs injected into mice inhibit miRNA activity [65]. For overexpressed miRNAs 
9 
 
which prompt tumor development, the delivery of antagomirs or antisense LNA probes, 
coupled with delivery of miRNAs which lead to tumor suppression are ideal [66]. It is 
additionally conceivable to transfect cells with miRNA in order to inhibit protein 
translation, rather than to promote protein translation. For example, let-7 miRNA 
transfection has been shown to reduce tumor growth in cancer cells [69–71]. Introduction 
of miR16 has also been shown to reduce tumor growth in prostate cancer cells [70]. In 
order to deliver the therapeutic agents, non-invasive delivery is desired, such as liposomal 
delivery. Recently, single-walled carbon nanotube (SWNT) delivery based on 
endocytosis has shown promise as a drug delivery alternative [71]. SWNTs have just 
appeared to deliver siRNA to cells [74-75], and thus can be applied to miRNA delivery as 
well. Additionally, the toxicity of SWNT can be substantially decreased by using smaller 
length SWNTs which are expelled quickly in the urine after use [74]. Prior to these 
therapeutic methods being used in humans, much research should be performed with 
respect to miRNA levels in healthy vs. unhealthy cells to guarantee that addition of 
antagomirs and/or miRNAs will not cause harm in the body by inhibiting or promoting 
expression of proteins which can bring about the onset of a different type of disease. 
1.4 miRNA Detection Methods  
 
Traditional methods for detecting miRNAs include Northern blotting, RT-PCR, 
microarrays, in-situ hybridization and others [77–79]. Most of the detection methods are 
based upon hybridization which relies on an optical label in order to translate the 
hybridization event into a measurable signal. There are label-free methods such as those 
of Raman spectroscopy [78]. In one particular example, silver nanorods are immobilized 
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on a substrate and the target nucleic acids are then adsorbed to the nanorods, resulting in 
Raman signal that is sequence-specific [78]. However, each of these methods has its own 
individual limitations.  
Northern blotting is the standard method for microRNA detection and used for detection 
of both mature and precursor forms of miRNA since it involves a size-based separation 
step. The Northern blotting protocol involves miRNA extraction, followed by 
polyacrylamide gel electrophoresis. Afterwards, separated sample is transferred to the 
blotting membrane, followed by visualization via hybridization with a complementary 
radioactively labeled probe [81–83]. A complication is that Northern blotting requires 
radiolabelling, which can introduce significant contamination, has low sensitivity and 
require a high amount of samples for miRNA detection [84–87]. Traditional northern 
blotting sensitivity problem has been minimized with the addition of locked nucleic acid 
(LNAs) to the probe sequences, increasing the detection sensitivity by almost 10-fold 
[85].  
 Quantitative reverse transcription polymerase chain reaction (qRT-PCR) is considered as 
the current gold standard technology for miRNA detection [76]. It is based on two 
consecutive and sequence-specific amplification steps of the miRNA of interest. The first 
step involves the synthesis of complementary DNA (cDNA) from extracted RNA using a 
reverse transcriptase (RT) enzyme [84]. However, two reactions are carried out, the first 
uses random primers to reverse transcribe all RNA in the samples to cDNA, which is then 
used to amplify an endogenous control [86].  The second reaction uses miR-specific RT, 
which reverse transcribes a single miRNA of interest only, using primers designed as 
hairpin loops due to miRNA short lengths [87]. qRT-PCR is capable of detecting the 
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minimal concentration of miR-target because of the two amplification steps. It has good 
detection efficiency, but they are time-consuming, requires highly purified samples and 
costly, thus limiting their use [88].  
Microarray is another method that can detect miRNA [77]. A widely used strategy for 
microarray analysis is fluorescent labeling of probe followed by hybridization of miRNA 
target to capture probes on the array. Like northern blotting, by incorporating LNA in the 
capture probes to recognize target miRNAs, the specificity of a microarray increases 
significantly [89]. miRNA microarrays have been used to study the biogenesis of 
miRNAs, differential miRNA expression profiles, disease characterizations, and stem cell 
development, to name a few applications [90]. Despite having the benefit of being less 
expensive and allowing a large number of parallel measurements, microarray lacks 
specificity, sensitivity and the ability to perform absolute quantification of miRNA 
abundance, thus limiting their use [91].  
The in-situ hybridization techniques can be subdivided into two groups as solid and 
solution phase hybridization methods. In a solid phase hybridization method, a capture 
probe is immobilized onto a solid surface to be hybridized with its complementary target 
[11], while in the solution phase, probe and complementary target are mixed and 
hybridized with each other [92]. However, this technique requires specialized equipment 
[93]. 
 A colorimetric detection method based on the use of plasmonic coupling effect has also 
been used for the detection of miR-21 [94]. Gold nanoplasmonic particles are assembled 
in a core-satellite configuration in the presence of target miRNA, inducing a remarkable 
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change in the scattering color and spectra at the picomolar level [95]. This approach 
works well and provides low detection limit, but a specialized nanotechnology platform 
is needed [95]. Therefore, development of more efficient and low-cost detection methods 
is very important. The development of simple and highly sensitive methods with the 
capability of clinical application also remains a great challenge. Thus, various methods 
are being developed, such as rolling circle amplification, enzyme repairing amplification 
and isothermal amplification method [98-99]. All these methods present enhanced 
sensitivity for miRNA detection, but each of these methods has its own individual 
limitations. In rolling cycle amplification method, more condition optimization is needed 
[89], while isothermal amplification has good sensitivity even as low as a single cell, but 
the required multiple enzymes increase the chance for errors and added costs, thus 
limiting their use [89]. Consequently, the discrimination of a perfect match (PM) versus a 
mismatch (MM) still remains a major challenge for probe-based hybridization method. 
Hence, it is important to design probes with specificity to recognize targets varying at just 
a single-base position in hybridization assays.  
There have been numerous real endeavors to enhance the specificity of probe-based 
hybridization for single MM separation over the years.  In addition to the conventional 
probes, different kinds of oligonucleotide probes have been developed, and some of them 
have been successfully demonstrated to achieve discrimination at a level of a single 
nucleotide MM [98]. One case is “molecular beacon” probes, which are oligonucleotide 
probes.  A molecular beacon (MBs) is a stem-loop hairpin structure consisting of a 
double strand stem approximately 4-6 base pair in length, containing donor and quencher 
fluorophore along with a single-stranded loop complementary to the target DNA or RNA 
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base sequence (Fig 1.3). In the absence of target the fluorescence of the donor is 
quenched, whereas, in the presence of target, the annealing of the MBs with the target 
leads to separation of the donor and acceptor fluorophore, resulting in fluorescence 
emission upon excitation. MBs are also very selective, differentiating targets with as little 
as a single base mismatch. One of the issues of using MBs for direct nucleic acid 
detection is no signal amplification, which limits sensitivity [98]. Also, Dual-labelling 
(fluorophore and quencher) process is relatively complex and expensive to synthesize.  
 
Figure 1.3: Hairpin-probe miRNA detection. Molecular beacons consisting of a stem and loop in absence and 





Recently, Smart probes (SPs) that take advantages of the selective quenching of 
fluorophores by neighboring guanine bases were introduced [99]. These probes are 
oligonucleotide probes just like MBs, but quenching is achieved by photoinduced 
intramolecular electron transfer upon contact with the guanine residues because of the 
guanine low oxidation potential [100]. These self-quenching SPs consist of a fluorophore 
on one end and multiple guanine bases on the opposing end are used as quenchers. 
Guanine bases were incorporated as part of the stem sequence to act as a quencher of 
fluorescence emission through interaction with the dye in close proximity. Thus, the main 
focus of this work is the development and characterization of SPs and to demonstrate 
their suitability for in vitro and sequence-specific detection of miRNA target sequence. 
Where necessary, enhancement of sequence-specificity of SPs is achieved by including 
nucleic acid blockers that are complementary to target sequences containing the 
mismatches. Thereby, these mismatched, non-targeted sequences are blocked and only 
the perfectly complementary sequence does consequently open the fluorescently labeled 
probe. Also, the nucleic acid blockers are straight oligonucleotides with no stem. These 
studies also show the inherent sensitivity of SPs and demonstrate that this method can 







1.5 Objectives   
 
Based on the numerous details explained in the introduction, the major objectives of this 
work is the design and characterization of the new Smart Probes (SPs) and demonstrate 
their suitability for in vitro and sequence-specific detection of miRNA target sequences. 
Another objective of this work is to show the inherent sensitivity of SPs and demonstrate 
that this method can accurately recognize even single-base mismatches. In order to 
accomplish this, the precisely planned objectives for this MSc research are highlighted 
below: 
 
 Development of smart probes suitable for the detection of miR-21 and let-7a 
targets. 
 Characterization of the new smart probes both in the presence and absence of the 
miR-21 and let-7a targets. 
  Demonstrate their suitability for sequence-specific detection of perfect miR-21 
and let-7a target sequences and recognizing even single-base mismatches. 
 Hybridization kinetics experiments. 
 Determination of figures of merit: sensitivity, limit of detection (LOD) and limit 




2 CHAPTER 2 
LITERATURE REVIEW 
 
2.1  miRNAs Hybridization and denaturation  
 
miRNAs are a class of small, single-stranded, non-protein coding RNA molecules that 
regulate cellular messenger RNA (mRNA) and protein level by binding to specific 
mRNAs [101]. mRNA hybridization is a fundamental process that describes the 
formation of a double-stranded structure from the binding of a single-stranded miRNA to 
its complement [102]. Based on the rule of Watson-Crick base pairing, the sequences of 
the two strands have to be complementary for hybridization. This results in the specificity 
of molecular recognition of one strand by the other via Watson-Crick base pairing during 
hybridization [103]. The energy release during hybridization is large enough to obtain 
stable hybrid. In a process termed ‘‘melting’’ or ‘‘denaturation’’ of the duplex, the bonds 
are disrupted. Denaturation and renaturation of miRNAs can be achieved repeatedly by 
slow heating and cooling, respectively, without altering the molecular integrity of each 





2.2 Oligonucleotide Probes and Hybridization  
 
An oligonucleotide probe or a single-stranded DNA sequence is used in a hybridization-
related assay to identify target DNA with complementary sequence [101]. It can be 
utilized to question and distinguish the complementary target DNA in an unknown DNA 
mixture that may be related in sequence to the probe. The presence of a specific sequence 
in a DNA sample is generally identified by hybridization using oligonucleotide probe 
with a complementary sequence. After mixing single strands of the probe with single 
strands of the target, probe DNA strands and the complementary target DNA strands can 
hybridize to form probe-target duplexes. [102] 
                                                           
2.3 Applications of Oligonucleotide Probes   
 
Oligonucleotide probes play a significant part in hybridization techniques including RNA 
interface, polymerase chain reaction (PCR) and microarray [102]. In situ hybridization is 
a common method for visualizing nucleic acid target within fixed tissue and cell type and 
is based on a method where RNA probe joined with a marker can hybridize to a specific 
target [102]. So far, oligonucleotide probes have been applied in various applied and 
basic research area. They are used for detection and quantification of particular nucleic 
acids, gene processing analysis, investigation of the relationship among various species 
and localization of nucleic acids in cells [103]. In medicine and ecological sciences, 
oligonucleotide probes play a crucial part in the identification of infectious agents, for 
example: recognition of gene responsible for pathogenesis, fungi, viruses, and bacteria 
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[98]. In pathology and heredity, they are utilized for hereditary screening of hereditary 
diseases, the hereditary fingerprint of individuals and determination of the distribution of 
specific sequences [104]. Also, in agriculture, they are helpful as an instrument for plant 
breeding [98]. When applied in environmental sciences, rRNA-targeted oligonucleotide 
probes are used as a part of the direct analysis of microbial population structures of 
complex natural and engineered frameworks [90]. 
 
2.4 miRNA Detection Technologies Developed in this Thesis    
 
Smart probes (SPs) are single-stranded hairpin-shaped oligonucleotide probes [105]. The 
inherent signaling property of SPs is due to their hairpin conformation [105-106]. The 
stem of the SPs consists of a fluorophore on one end and multiple guanine bases on the 
opposing end are used as quenchers. In the absence of complementary target sequences, 
they form a stem-loop hairpin structure that results in quenching of the fluorophore’s 
fluorescence [107]. Hybridization of the SP’s loop sequences with target sequences opens 
the hairpin and separates the fluorophore from the quenching guanine residues. The 
structure of our hairpin oligonucleotide probes is analogous to molecular beacon hairpins 
(MBs) [108-109]. A molecular beacon consists of a single-stranded DNA molecule in a 
stem-loop conformation with a donor fluorophore and a quencher. A commonly used 
quencher, 4-(4’-dimethylaminophenylazo) benzoic acid (dabcyl) is a chromophore [109]. 
Dabcyl, a neutral and hydrophobic molecule can serve as a universal quencher for a 
variety of fluorophore, but the quencher in MBs is replaced with multiple guanine 
residues in SPs [50, 106]. Despite the wide applications and the sensitivity and selectivity 
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of MBs, they have several limitations [110]. Dual-labeling (fluorophore and quencher) 
process is relatively complex and expensive to synthesize [110]. Thus, in contrast to 
MBs, SPs are only labeled at one end with a fluorescent dye. The major advantage of SPs 
as compared to MBs is that unlabelled oligonucleotides are relatively easy to synthesize 
(single labeling) and have free terminus at the guanosine end for further modification 
[111]. For instance, MB requires site-specific labeling of each terminus of the hairpin 
with two extrinsic molecules, a donor, and a quencher [112]. In the SP, the fluorophore is 
attached to one end of the oligonucleotide and quenched by guanosine residues in the 
complementary stem via photo-induced intramolecular electron transfer [112-113]. Upon 
hybridization to the target sequences, the fluorescence is restored due to a conformational 
reorganization that forces the stem strands apart [89, 105]. The SP is relatively easy to 
synthesize and have a free terminus at the poly-guanosine end for further modification 
[99]. Due to the increase in fluorescence intensity upon hybridization, SP has been used 
for various detection assays. For instance, monitoring of DNA polymerase fidelity [99], 
detection of UV-induced DNA photodamage [10], and detection of glutathione and 
cysteine in human plasma and cells [114].   
This study developed SPs to recognize miRNAs, with lengths of about 22 nucleotides. 
The SPs developed were used in homogeneous assays for detecting miR-21 and let-7a, 
and their analogous single-base mismatch sequences. The miR-21 and let-7a target 
sequences are specifically recognized by the loops of the individual SPs. Survey of the 
literature has shown that one of the most widely studied cancer biomarkers is miRNA.  In 
case of cancer, microRNA-21 (miR-21) can act either a tumor suppressor or as oncogenes 
[3-6]. However, miR-21 has been specifically implicated in several types of cancer, 
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including breast, lung, prostate, liver, stomach colon, and pancreatic cancer [1-2]. 
Various techniques have been adopted for the detection of microRNA. For example; 
Tugba Kilic et al [92] successfully used electrochemical-based method for the detection 
of miR-21 in breast cancer cells.  Jiyun Part et al [96] used colorimetric platform for 
detection of miR-21 based on nanoplasmonic core-satellite assembly. Guichi Zhu et al 
[115] have used a quencher-free fluorescent method for homogeneous sensitive detection 
of let-7a in human lung tissues. A method of Tungsten Disulfide (WS2) nanosheet-
mediated fluorescence quenching and duplex-specific nuclease signal amplification was 
adopted by Qiang Xi et al [116] for miR-21 detection. Partha Pratim [117] successfully 
developed a platform for fast detection of let-7 microRNA using polyaniline fluorescence 
and image analysis techniques. A real-time PCR method was adopted by Hong-He Zhang 
et al [118] for detection of let-7a in gastric carcinoma.  
SPs were employed in this research work due to their excellent signaling property.  It 
must also be stated that the aim of this work is to develop new smart probes (SPs) and 
homogeneous assays and to demonstrate their suitability for in vitro (and possibly, in 
vivo), sequence-specific detection of miR-21 and let-7a target sequences.  However, 
these studies also show the inherent sensitivity of SP and demonstrate that this method 
can accurately recognize even single-base mismatches. It is expected that this work will 
build research competence in analytical method development and also represent a simple, 





2.5 How Smart Probes Work    
 
Smart probes (SPs) are single-stranded nucleic acid molecules that possess a stem-and-
loop structure (Fig 2.1). The ends of the probe contain a fluorophore and guanine base 
molecules. The loop portion of the molecule is complementary to the target sequences. 
The arm sequences are unrelated to the target sequence. A fluorophore is attached to one 
arm and multiple guanosine residues are attached to the end of the other arm. The close 
proximity of the guanosine residue and fluorophore causes the quenching of the 
fluorescence emission of the fluorophore. As shown in Figure 2.1, in the absence of 
target, the stems would hybridize with each other due to their close proximity and the SPs 
would form a hairpin structure. This would bring the dye very close to the guanine bases 
and induce dye-guanine interaction, which causes a significant reduction in the 
fluorescence of the dye. When the SPs encounter target sequences, SPs hybridize to their 
specific target sequence causing the hairpin-loop structure to open and separate the 
fluorophore from guanosine residues; it forms a hybrid that is longer and more stable than 
the hybrid formed by the arm sequences. Since nucleic acid double helices are rigid 
[105], the formation of SP-target hybrid rules out the simultaneous existence of a hybrid 
formed by the arm sequences. Since the fluorophore is no longer in close proximity to the 
guanine residues, fluorescence emission takes place. The measured signal is directly 















3 CHAPTER 3 
EXPERIMENTALS 
3.1  Introduction  
 
This chapter explains experimental details related to Smart Probes (SPs) characterization 
both in the presence and absence of the target sequence.  The concept and experimental 
techniques of the various characterization methods used are concisely explained. 
 
3.2 Materials and Reagent  
 
Two smart probes and their corresponding oligonucleotide target sequences used in this 
study were custom synthesized and purified by Integrated DNA Technology, BVBA, 
Leuven, Belgium and are summarized in Table 3.1 and 3.2. All reagents were of 
analytical grade; sodium hydroxide (NaOH) (Fluka AG, Buchs, Switzerland), sodium 
chloride and magnesium chloride hexahydrate (MgCl2.6H2O) were purchased from 
(Fisher Scientific Company, New Jersey, NJ, USA) and (BDH Chemical Ltd. Poole, 
England) respectively. Hydrochloric acid and ethylenediaminetetraacetic acid (EDTA) 
were both obtained from BDH Chemical Ltd. (Poole, England). Tris was purchased from 
Sigma-Aldrich, (St. Louis, MO, USA). All chemicals were used as received. Nanopure 
water from a water purification system (Thermo Science, Waltham, MA, USA) was used 
for all solutions. Oligonucleotide samples and smart probe (SP) were each suspended in 
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nanopure water and were separated in aliquots and kept frozen at -20 
o
C until needed.  
After thawing, miR-21 was diluted in buffer (20 mM Tris, 2 mM EDTA, pH 7.5) in the 
presence of 200 mM NaCl and 3 mM MgCl2, while let-7 was diluted in buffer (20 mM 
Tris, 2 mM EDTA, pH 7.5) in the presence of 200 mM NaCl and 20 mM MgCl2 to gives 
desired concentration. The concentration of diluted oligonucleotide solutions were 
confirmed by using UV-Visible spectrophotometer (Genesys 10S UV-Vis 


















































aThe underlined bases indicate the stem sequences, while the three G’s on the 3’ end is not part of the stem 
hybrid but are included as quenchers for the fluorophore. 
 bThe underlined bases in RNA2, RNA2b and RNA4 is the single-base mismatch, whereby the corresponding rG 
in RNA1 has been replaced by rC in RNA2 and RNA2b and by rU in RNA4. 
 cThe difference between RNA2 and RNA2b as compared to the RNA4 is in the location and type of the single-
base mismatch.  
dThe underlined bases in RNA3 is the double-bases mismatch, whereby the corresponding rA and rG have been 































Let-7b mismatch target 
 sequence blocker 
AACCACACAACCTACTACCTCA 
Let-7c  mismatch target  
sequence blocker 
AACCATACAACCTACTACCTCA 
aThe underlined bases indicate the stem sequences, while the three G’s on the 3’ end is not part of the stem 
hybrid but are included as quenchers for the fluorophore.  
bThe underlined bases in Let-7b and let-7c are double-bases and single-base mismatch, respectively, whereby the 
corresponding rA in Let-7a has been replaced by rG in Let-7b and let-7c. 
cThe difference between let-7b and let-7c is the number of base mismatch.  
 
3.3 Fluorescence Measurements   
 
The picture of a typical fluorescence spectrophotometer measurement setup is depicted in 
Fig 3.1. In brief, xenon lamp was employed as the excitation source. Fluorescence 
emission spectra were recorded in the range from 500 and 650 nm at an excitation 
wavelength of 490 nm. The emission wavelength of 520 nm was used for data analysis. 
The excitation and emission slits were set to 3.0 and 3.0 nm, except for calibration data, 
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where they were both set to 5.0 nm. A 10-mm path, sub-micro quartz cuvette was used 
for these measurements. A thermo-electrically cooled sample holder inserted in the 
fluorescence spectrophotometer regulated sample temperatures and TC125 temperature 
control unit (Quantum Northwest Inc., USA) was employed for changing the 
temperatures. For all the miR-21 thermal transition profile fluorescence measurements, 
100 nM SP was mixed with 300 nM target (1:3 molar ratios in Tris-EDTA buffer). These 











Figure 3.1: Picture of FLS 920 fluorescence spectrometer setup. 
 
Fluorescence spectra of the incubated samples were measured using FLS920 fluorescence 
spectrophotometer. The spectra were recorded at room temperature on a 400 μL aliquot of 
the SP-oligonucleotide hybridization mixture. The temperature-dependent fluorescence 
measurements were carried out on buffer solutions of the SPs incubated in the presence 
or absence of the target oligonucleotide sequences.  The temperature was varied from 20 
to 78 
o
C in 2 
o
C increment, with 100 seconds settling time. For fluorescence 
measurements involving Let-7 SP in the presence of perfect target sequence, 100 nM SP 
was mixed with the 300 nM target (1:3 molar ratios in Tris-EDTA buffer). The 
experiments were repeated with imperfect targets that include single and double bases 
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mismatch, both in the absence of and in the presence of mismatch sequence blockers. 
These experiments were performed with individual mismatch sequences on the one hand, 
and all three targets (let-7a, let-7b and let-7c) as a mixture on the other hand, in the 
presence of blockers. For the individual mismatch targets, 50nM SP was mixed with 
150nM mismatch sequence in the presence of 300nM mismatch sequence blockers (1:3:6 
molar ratios in Tris-EDTA buffer).  
For fluorescence measurement involving all three target in the absence of mismatch 
sequence blockers, 150 nM SP was mixed with 150 nM each of the three targets (let-7a, 
let-7b, and let-7c) respectively (1:1:1:1 molar ratio in Tris-EDTA buffer). Also, for 
fluorescence measurements performed in the presence of blockers, 150 nM SP was mixed 
with 300 nM excess of two mismatch blockers ( let-7b and let-7c), in the presence of 150 
nM of all the three targets ( let-7a, let-7b, and let-7c ) respectively.  
The SP-Let-7a concentration-dependent experiment used 100 nM SP in the presence of 
varying concentrations of target oligonucleotide sequence (0-1000 nM) and incubated in 
the dark at room temperature for around five hours prior to fluorescence measurements. 
For hybridization kinetic fluorescence measurements at room temperature, 100 nM SP 
was mixed with 300 nM target oligonucleotide sequence (1:3 molar ratios in Tris-EDTA 
buffer) in a reaction volume of 400 μL. Fluorescence intensity was measured at specified 
time intervals, immediately after mixing of an oligonucleotide with SP. Meanwhile, for 
kinetic experiments at 37 
o
C, fluorescence spectra were measured at specified time 
intervals, immediately after the mixing of an oligonucleotide with SP that has been 
thermostated at 37 
o
C for several minutes.  
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4 CHAPTER 4 
RESULTS AND DISCUSSION  
 
4.1  Design of the Smart Probes for the detection of miR-21 target   
 
MicroRNA detection is very important to the understanding of cancer prognosis and 
progression. In order to develop methods for miRNA detection, hairpin probes have been 
designed. Smart probes (SP) are hairpin-shaped oligonucleotide probe molecules with a 
fluorophore on one end and multiple guanine bases on the opposing end are used as 
quenchers. The SP was precisely designed to maximize its performance as a specific and 
selective probe. The SP contained 41 nucleic acids bases (see Table 3.1). As for the target 
and mismatch sequences, the sequence of miR-21 (herein called RNA1) is perfectly 
complementary to the loop of the SP, while three others (RNA2, RNA2b, and RNA4) 
have a single-base mismatch in the complementary loop sequences (underlined, Table 
3.1). Also, sequence RNA3 have two-base mismatches with the loop of the probe 
(underlined, Table 3.1). The loop sequence of the SP contained a 22-nucleotide-long 
sequence that is perfectly complementary to the miR-21 target sequence (Fig 4.1). The 
stem hybrid comprises of 8 nucleobases on each side (Fig 4.1). The fluorophore dye, 6-
FAM (6-carboxyfluorescein) is on the 5’ end, and the multiple guanosine bases are on the 
3’ end. To optimize the quenching by the guanosine residues, three of which form part of 
the stem and complementary to the cytosine residue on the 5’ side of the stem and the 
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Figure 4.1: Structure of the SP and that of SP-RNA1 duplex and their Tm. The sequence of the miR-21 target is 
also shown (top right). setup. 
 
The SP used in this thesis work was carefully designed to optimize its performance as a 
specific and sensitive probe for the miR-21 sequence. Since SPs have essentially the 
same properties and conformational structure as molecular beacons [MB], except for the 
absence of quencher component that is incorporated in molecular beacons, the factors 
affecting SP hybridization and their temperature-dependent conformation, such as 
melting temperature of the loop and the stem and target to probe concentration are similar 
to those of MB [119]. In light of the thermodynamic stability of MB, a functional MB or 
SP ought to have its stem more thermally stable than the SP-target duplex [109]. 
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Optimization of the SP for sequence-specific detection was accomplished by ensuring 
that the stem melting temperature is sensibly higher than the SP-target hybrid melting 
temperature (Tm). This ensures that the stem remains intact as a hairpin at relatively high 
temperature when the SP-target hybrid has melted. These considerations have been 
factored in to ensure the correct design and performance of the SP. As shown in Fig 4.1, 
the Tm of the SP is 64 
o
C, while that of SP-RNA1 sequence hybrid is 50 
o
C. Thus, the Tm 
of SP-RNA1 hybrid is 14 
o
C lower than that of SP alone. Therefore, based on the hybrid 
Tm, these SP possesses excellent specificity and sensitivity.   
 
4.2 Thermal Transition Profile   
 
SPs should exhibit a conformational change upon heating that is consistent with their 
design. When the temperature of a solution containing SP is increased, fluorescence 
increases in a manner that is characteristic of the melting of the double-stranded nucleic 
acids [108]. To ensure correct design and optimal performance of the SP, thermal 
denaturation profiles of the SP alone and SP-RNA1/RNA2/RNA2b/RNA3/RNA4 
duplexes were measured. Figure 4.2 shows the thermal transition profiles derived from 
the heating cycle for the SP and SP-target hybrids for the five oligonucleotide sequences.  
In Fig. 4.2, the thermal transition profile of SP alone confirms that at low temperature the 
SP exists in the hairpin form, and the fluorescence of the fluorophore is quenched by the 
guanines residue on the 3’ end (black, Figure 4.2). However, as the temperature is 
increased to about 58 
o
C, the stem hybrid begins to melt, and the fluorophore separates 
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from the guanine residues. When the temperature is further increased, the fluorophore 
and the guanine residue are separated further, until the stem hybrid completely melts.  
 
Figure 4.2: Thermal transition profiles of SP (black), SP-RNA1 (red), SP-RNA2 (green), SP-RNA2b (blue), SP-
RNA3 (cyan) and SP-RNA4 (magenta) target sequences. Each measured fluorescence intensity has been 







This is evidenced by an increase in fluorescence intensity with increase in temperature 
between 58 and 70 
o
C.  Beyond this point, the SP stem adopts a random-coil 
conformation and the fluorescence intensity goes down slightly. 
In the presence of a three-fold excess of perfectly complementary miR-21 target sequence 
(RNA1), the fluorescence intensity was very high at low temperature (red, Figure 4.2), 
because the miR-21 target sequence hybridized with the loop sequence of the SP, 
resulting in the SP undergoing a spontaneous conformational change that forces the 
fluorophore and the quenching guanine residues apart. As the temperature was gradually 
raised further, fluorescence begins to decrease, which suggests the stable hybrid is 
gradually melting and the fluorophore and guanine quencher are moving closer, due to 
the SP forming a hairpin. This decrease continues with an increase in temperature until 
the RNA1 target completely melts away from the SP and the SP assumes the hairpin 
conformation, with the fluorophore in contact with the guanosine residues, which 
indicated the lowest point on the curve (red, Figure 4.2). As the temperature is further 
increased, the stem of the hairpin then gradually melts and the fluorescence intensity 
begins to increase again until the stem adopts a random-coil conformation and the 
fluorescence is decreases further. The Tm of SP-RNA1 was determined to be 50 
o
C and 
the difference in Tm between SP alone and SP-target duplex is 14 
o
C. This difference in 
Tm suggests excellent recognition of the RNA1 target sequences by the smart probes and 
specificity of the new SP developed. There is about a three-fold increase in fluorescence 
intensity at 20 
o
C when the fluorescence intensity of the SP alone is compared to the SP-
RNA1 sequences. This intensity increase is consistent with that reported previously for 
SP [110].  
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A similar pattern is observed when there is single (green, blue, and magenta Figure 4.2) 
and double (cyan, Figure 4.2) base mismatches in the target sequences, with relatively 
low melting temperatures. The shape of the thermal transition profile is similar to that of 
SP-RNA1 (red, Figure 4.2) and the difference in Tm between SP alone and the SP-target 
duplex (21 
o
C for SP-RNA2 sequence, 16 
o
C for SP-RNA2b sequence, 18 
o
C for SP-
RNA3 sequence  and 24 
o
C  for SP-RNA4 sequence) suggest the specificity of this  new 
probe for preferentially detecting the target miR-21 sequence against the mismatch 
sequences. 
 
4.3  Enhanced Temperature-Dependent Discrimination   
 
Figure 4.2 suggests a number of ways for discriminating between the miR-21 target 
sequence, RNA1, and the mismatch sequences, RNA2, RNA2b, RNA3 and RNA4. This 
includes measurement of the thermal transition profiles to decide the Tm for each 
situation; and single-point estimation of the fluorescence intensity at a high temperature 
of around 56 
o
C.  The ideal approach to discriminate between RNA1 and the four 
mismatches RNA2, RNA2b, and RNA3 and RNA4 duplexes is by measuring the 
fluorescence intensities of all five duplexes around 56 
o
C. Due to the fact that at this 
temperature, fluorescence intensity produced by each of SP-RNA2, SP-RNA2b, SP-
RNA3 and SP-RNA4 sequence hybrid is significantly quenched, much like that of SP 
alone (Figure 4.2). Then again, SP-RNA1 target hybrid gives a substantially higher 
fluorescence signal at 56 
o
C. Hence, looking at the fluorescence signal at 56 
o
C for each 
of the five duplexes (SP-RNA1, SP-RNA2, SP-RNA2b, SP-RNA3 and SP-RNA4), the 
signal produced by RNA1 is around 165% that of SP-RNA2, SP-RNA2b, SP-RNA3 and 
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SP-RNA4 (Figure 4.3). This implies that at 56 
o
C, SP is hybridized with the RNA1 and 
accordingly fluoresces, while SP is not hybridized with RNA2, RNA2b, RNA3 and 
RNA4, resulting in a fluorescence signal that is quenched. In this way, by measuring the 
fluorescence signal at 56 
o
C, miR-21 target sequences can be specifically detected while 
the fluorescence signal from mismatch sequences is significantly quenched. Thus, this SP 
has shown the inherent sensitivity and demonstrated that this method can accurately 
recognize mismatched sequences.  
 
Figure 4.3: The miR-21 sequence discrimination at 56 oC. This data was extracted from thermal transition 





4.4  Hybridization Kinetics Measurements   
 
SPs hybridize spontaneously to their target at room temperature and undergo a 
conformational change that results in the generation of fluorescence. Hybridization 
process of the SP with miR-21 (RNA1) at room temperature took around five hours to 
complete (Figure 4.4). This SP-target hybridization kinetics is consistent with the 
previously reported hybridization involving SPs and MBs [108-109]. However, five 
hours is a fairly lengthy time-frame if this technique is to be adapted for quick diagnostic 
applications. Therefore, the time-dependent investigation was performed at 37 
o
C, so as 
to accelerate the SP-target sequence hybridization and to be consistent with body 
temperature (see Figure 4.5). As shown in this Figure, complete hybridization process at 
37 
o
C took just 40 minutes. This figure indicates that the hybridization process was so 
fast that the reaction was completed in 40 minutes for SP-target sequence, which is 
around seven times speedier than room temperature. Thus, the hybridization process can 




























4.5 Concentration-Dependent Measurements   
 
To demonstrate the performance of this SP-based assay, concentration-dependent 
measurements were carried out. Different concentrations (0 to 1000 nM) of RNA1 was 
incubated with 100 nM SP for about 5 hours, followed by fluorescence intensity 
measurements. The fluorescence intensity of RNA1 increased with the increasing RNA1 
concentration until RNA1 concentration of 100 nM. Thus, the calibration plot is linear in 
the 0-100 nM RNA1 concentration range (Figure 4.6), and the curve becomes nonlinear 
beyond 100 nM RNA1 target concentration (Figure 4.6 and 4.7). As shown in Figure 4.6, 
the detection limit of 0.53 nM (LOD = 3σb1/m) was achieved. The limit of quantitation 
was found to be 1.76 nM (LOQ = 10σb1/m), where σb1 is the standard error of 3 replicate 
measurements of the blank (100 nM SP) and m is the slope of the calibration plot (Figure 




 (Sensitivity = slope of the calibration plot) 


















Figure 4.7: Concentration-dependent plot for 100 nM SP in the presence of different concentrations of RNA1 (0-








5 CHAPTER 5 
Detection of Let-7a Cancer Biomarker Using a Smart Probe     
5.1  Design of a Smart Probes for the detection of Let 7 target   
 
The design principle of the new proposed smart probe (SP) is illustrated in Figure 5.1. 
The SP consists of a total of 37 nucleic acids bases, while the target sequences are the 
perfect sequence of Let-7a, and its corresponding double-base and single base mismatch 
sequence (Let-7b and Let-7c) respectively (see Table 3.2). The SP was synthesized with a 
22-nucleotide loop that is complementary to this target sequence and a stem composed of 
6 nucleobases on each side (Figure 5.1). The SP was labeled with a 6-FAM fluorophore 
on the 5’-end of the stem and with a 3-G quencher on the 3’ ends (Figure 5.1). In addition 
to the 3-G quencher, more G bases are incorporated in the stem to further enhance the 
quenching. The SP stem sequence is only involved in the hairpin formation, not in 
binding to the target sequences.  
The SP was carefully designed to optimize its performance as a specific and sensitive 
probe for Let-7a sequence. Optimization of the SP for sequence-specific detection was 
accomplished by ensuring that the stem melting temperature is sensibly higher than the 
SP-target hybrid melting temperature (Tm). This ensures that the stem remains intact as a 
hairpin at relatively high temperature when the SP-target hybrid has melted. These 
considerations have been taken into account in ensuring the correct design and 
performance of the SP. As shown in Fig 5.1, the Tm of the SP is 58 
o
C, while that of SP-
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Let 7a hybrid is 48 
o
C. Thus, the Tm of SP-Let 7a hybrid is 10 
o
C lower than that of SP 
alone. Therefore, based on the hybrid Tm, the desired performance characteristic on the 
SP has been met. 
 
Figure 5.1: Structure of the SP and that of SP-Let 7a hybrid and their melting temperatures. The stem 
sequences of the SP are underlined in the SP-Let 7a hybrid (bottom right) for easy correlation with the structure 












5.2  Thermal Transition Profiles   
 
To ensure the correct design and performance characteristics of the new SP, thermal 
transition profile of the new SP was measured. Also, in order to ensure that SP can 
optimally recognize target oligonucleotide sequences, the SP stem must be closed and 
exhibit minimum fluorescence in the absence of target sequence, while in the presence of 
perfectly complementary target sequence, the SP must form a stable SP-target hybrid and 
exhibit maximum fluorescence. In addition, in the presence of mismatch sequences, the 
SP stem should somewhat keep the closed state, since the hybridization of the SP to the 
sequence that contains the mismatch form a less stable hybrid. 
 
5.2.1 Thermal Transition Profile in the Absence of Blockers  
In Fig 5.2 (black), the thermal transition profile of SP alone shows that at a lower 
temperature the SP still keeps the closed state, and the fluorescence is significantly 
quenched. However, as the temperature is increased, the stem hybrid begins to melt and 
the fluorophore and the quenching guanine residues move away from each other. When 
the temperature was further increased, the stem hybrid adopts a random-coil 
conformation and the fluorescence intensity goes down slightly. The Tm of the SP was 
determined to be 58 
o
C. 
In the presence of a three-fold excess of Let-7a target sequence that was perfectly 
complementary to the loop sequence of the SP, the thermal melting curves are reverse, 
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Figure 5.2: Thermal transition profiles of SP (black), SP-Let 7a (red), SP-Let7b (green) and SP-Let7c (blue), 









significantly as the temperature is slowly increased. In the presence of Let-7a target, the 
highly fluorescent SP-Let 7a duplex hybrid forms spontaneously at low temperature. As 
the temperature is increased, the SP-Let 7a duplex becomes destabilized, the SP separates 
fully from the Let-7a target and forms its hairpin structure and the fluorescence is 




A similar pattern is observed when there is single (blue, Figure 5.2) and double (green, 
Figure 5.2) base mismatches in the target sequences. The shape of the thermal transition 
profile is similar to that of SP-Let 7a (red, Figure 5.2) and the differences in Tm between 
SP and the SP-target duplex ( 9 
o
C for SP-Let 7b and SP-Let 7c  sequence respectively) 
suggest the specificity of this new probe for detecting the Let-7a sequence is poor. The 
results show that all three target sequences produce transition profile that are overlapping, 
so there is no difference between let-7a, let-7b, and let-7c target sequence because the 
sequences are so similar. These results are consistent with what was predicted for the Tm 
of the hybrid of SP with each of let-7a, let-7b and let-7 by OligoAnalyzer, a software 
used to predict melting behavior and Tm of oligonucleotide probes and their target 
hybrids. Let-7a, let-7b and let-7c all have essentially the same Tm under similar 
conditions. While this observation is a disadvantage, it in fact suggests that this new SP 
can in fact be used as a universal probe for Let-7a, let-7b and let-7c sequences. In order 
to enhance the specificity of the SP for let-7a and discriminate this target from the 
mismatch sequences of let-7b and let-7c, we use nucleic acid blockers. The nucleic acid 
blockers are unlabeled and perfectly complementary to mismatch sequences so that they 
can preferentially hybridized with such mismatch sequences, thereby preventing the SP 
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from hybridizing with such mismatch sequences (see Table 3.2). So, if this new SP is to 
be used for one target, we have to add blockers for other two targets. Therefore, instead 
of designing a different probe for the three let-7 targets, one can make use of this same 
probe for all the three targets.  
 
5.2.2 Thermal Transition Profile in the Presence of Blockers  
When the SP was mixed with a six-fold excess of Let-7b blockers sequence, and then 
followed by a three-fold excess of double-base mismatch sequence (Let-7b), the 
fluorescence intensity for SP-Let-7b hybrid is very low at low temperature (green, Figure 
5.3). This is because the hybridization of the fluorescent SP to the Let-7b sequence 
containing the mismatch is blocked by the nucleic acid blockers and consequently no 
significant increase in fluorescence is found, so the SP is in the closed state. The let-7b 
blockers is perfectly complementary to Let-7b sequence. Also, the blockers are linear 
oligonucleotides and so have no stem-loop structure (see Table 3.2). However, as the 
temperature is increased, the stem hybrid of the SP begins to melt and the fluorophore 
and the guanine residues move away from each other. When the temperature was further 
increased, the stem hybrid adopts a random-coil conformation, in which case the 
fluorescence intensity go down slightly. For this profile, the Tm of the SP-Let7b hybrid in 
the presence of let-7b blockers was determined to be 57 
o
C (green, Figure 5.3). The Tm is 
essentially the same as that of SP, showing that the SP does not hybridize with Let-
7b.When the SP was mixed with a six-fold excess of Let-7c blockers sequence in the 
presence of a three-fold excess of single-base mismatch sequence (Let-7c), low-intensity 
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signal was obtained at low temperature with a thermal profile similar to that of SP (blue, 





Figure 5.3: Thermal transition profiles of SP (black), SP-Let 7a (red), SP-Let7b in the presence of let-7b 
blockers (green) and SP-Let7c hybrid in the presence of let-7c blockers (blue). Each measured fluorescence 








When the SP was mixed with a six-fold excess of the two blocking oligonucleotides ( 
Let-7b and let-7c blockers) in the presence of a perfectly complementary Let-7a target 
sequence (Let-7a) and each of the two mismatches target sequences (Let-7b and let-7c 
sequences), the fluorescence intensity is very high at low temperature (blue, Figure 5.4).  
This is because the perfectly matched target sequence let-7a hybridized with the loop of 
the SP, and the fluorescence signal is recovered because the unfolding of SP increase the 
spatial distance of fluorophore and quenching guanine residues whereas the mixture of 
the mismatched sequences is effectively blocked by let-7b and 7c blockers. When the 
perfectly matched target sequence and the mismatched sequences are simultaneously 
present, the SP appeared to have hybridized with the perfect target sequence and the 
mismatched sequences, hence the observed approximately 15% decrease in fluorescence 
signal around 20 
o
C when compared to the mixture of the perfect and mismatched target 
sequences in the presence of let-7b and 7c blockers (green, Figure 5.4). This is because 
the SP appears to be competing with all the targets: perfect sequence let-7a and the 
mismatch sequences Let-7b and Let-7c, which may have brought down the intensity a 
little bit when 7b and 7c blockers were not present. The shape of the thermal transition 
profile for SP alone (black, Figure 5.4) and SP-target hybrid (red, Figure 5.4) are similar 
to those found for SP alone and SP-target hybrid in above reports (Figure 5.2). Thus, it is 
noteworthy that this method shows excellent specificity and sensitivity of the new SP 
using nucleic acid blockers and it enables efficient discrimination between perfect target 






Figure 5.4: Thermal transition profiles of SP (black), SP-Let7a (red), SP-Let7a-let7b-let7c without blockers 
(green), and SP-Let7a-let7b-let7c in the presence of let-7b and 7c blockers  (blue). Each measured fluorescence 
intensity has been normalized to the intensity at 78 oC. This is a single-pot experiment where SP-Let-7a, was 













5.3 Enhanced Temperature-Dependent Measurements    
 
Figure 5.3 suggest possible ways of discriminating between the target sequence, Let-7a 
and its analogous mismatch sequences (Let-7b and Let-7c). This includes: measuring the 
thermal denaturation profile to determine the melting temperature in each case and 
single-point measurement of the fluorescence signal of all the three duplexes at 20 
o
C. 
This is because the fluorescence intensity produced by SP-Let 7a at this temperature is 
very high whereas the fluorescence signal produced by SP-Let 7b and SP-Let 7c duplexes 
is quenched in the presence of blockers, just like that of SP alone (Figure 5.3). Thus when 
fluorescence intensity was measured at 20 
o
C for all the three duplexes (SP-Let 7a, SP-
Let 7b and SP-Let 7c), the intensity produced by SP-Let 7a hybrid is around 180% that of 
SP-Let 7b and SP-Let 7c (Figure 5.5). Hence, at 20 
o
C, the SP is hybridized with Let-7a 
whereas the hybridization of the SP to the sequences containing mismatches (Let-7b and 
Let-7c) is prevented by the nucleic acid blockers and therefore produced fluorescence 
intensity that is significantly quenched. Thus, it can be clearly seen that the use of these 












5.4  Concentration-Dependent Measurements    
 
In order to determine the sensitivity and performance of the SP assays, concentration-
dependent measurements were carried out. Different concentrations (0 to 1000 nM) of 
Let-7a were hybridized with 100 nM SP and then followed by fluorescence intensity 
measurements. The fluorescence intensity of SP-Let-7a hybrid increased with increasing 
Let-7a concentration until 200 nM. The calibration curve is linear in the 0-5 nM Let-7a 
concentration range (Figure 5.6), and the curve becomes nonlinear beyond 5 nM Let-7a 
target concentration (Figure 5.6 and 5.7). As shown in Figure 5.6, the detection limit of 
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0.02 nM (LOD = 3σb1/m) was achieved. The limit of quantitation was found to be 0.07 
nM (LOQ = 10σb1/m), where σb1 is the standard error of 3 replicate measurements of the 
blank (100 nM SP) and m is the slope of the calibration plot (Figure 5.6). The sensitivity 
















Figure 5.7: Concentration-dependent plot of 100 nM SP in the presence of different concentrations of Let-7a (0-













5.5  Comparison of the Developed Method to Prior Methods           
 
Comparing the SP-based method developed in this work to the methods outlined in the 
introduction, the method is quite simple and specific, with the detection limit in 
nanomolar concentration range. This technique is like PCR based techniques in term of 
sensitivity. On the basis of simplicity and cost, the SP-based method is an improvement 
over the PCR detection method because PCR is time-consuming and costly [104].   
The northern blot method presents low sensitivity than the method presented in this work, 
it is complex and requires radiolabeling [87-90], while this new method is less 
cumbersome and simpler. Also, the high cost of fluorescence quencher-based techniques 
makes their potential use for multiplex analysis of a large number of different specific 
target sequences difficult and unattractive [35]. Also, this SP method is very fast, taking 
40 minutes to detect target if the SP and target were incubated at 37 
o
C This SP-based 
method gives nanomolar sensitivity. Thus, this SP-based method is quite simple, enzyme-
free and rapid, and it provides high specificity for the target sequence.  It is notable that 
the technique presented here shows excellent specificity since we apply nucleic acid 









6 CHAPTER 6 
 CONCLUSION      
7 In this work, we have successfully designed and characterized two new SPs for 
highly specific detection of miRNA in a homogenous assay format. Each SP consists 
of a dye-labeled stem-loop structure that undergoes conformational change upon 
specific hybridization to the target sequence. The loop sequence of each SP is 
perfectly complementary to the miRNA sequence of interest. The thermal transition 
of each SP shows that the SP can give a fluorescence intensity increase of about 
three-fold when it is bound to a perfectly complementary target. Our result shows that 
each SP has excellent sensitivity and specificity which make it suitable to 
discriminate between perfect targets and mismatch target sequences. It was 
additionally discovered that recognition of miRNA target with the SP finished in 
around 40 minutes if the two components were incubated at 37 
o
C. This SP-based 
method is very fast, simple, cheap and less cumbersome when contrasted with other 
methods reported for miRNA detection. Also, this SP gives nanomolar sensitivity. 
Compared with other miRNA detection methods, this method shows high sensitivity, 
improved mismatch discrimination and decreased cost due to high fluorescence 
quenching efficiency of the use of a single-label probe. Therefore, the simplicity, 
cheap cost and excellent specificity of the new SPs make them suitable tools for fast 
in vitro detection of miRNAs. The assay reported here gives a detection limit of (0.53 









) for miR-21 and Let-7a respectively. The detection 
sensitivity reported here is in nanomolar concentration which is consistent with 
literature results for MB and SP-based methods. This new SP-based method does not 
involve any amplification steps. Therefore, the SP-based method presented here is 
fast, simple and specific, and represent a unique platform for homogenous assay 
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